HEALTHBLOOMBERG
FDA to Review Easing Restrictions on Peptides
The FDA is set to review potential changes to restrictions on peptides. The review focuses on easing existing limitations related to these compounds.
Mentioned
Related Signal
Adjacent reporting
- The FDA considers easing limits on peptides use
- FDA to weigh easing limits on unproven peptides favored by RFK Jr. and other MAHA figures
- FDA to weigh lifting restrictions on some MAHA-favored peptides
- Peptides may soon be easier to get amid RFK Jr's push, but experts warn of risks
- RFK Jr.'s peptide push could become next wellness boom